For decades, fatty liver disease, and its more severe inflammatory progression known as metabolic dysfunction-associated steatohepatitis (MASH), remained largely overlooked…
Read More
MIT Engineers Pioneer Dual-Mode Propulsion System to Revolutionize Small Satellite Maneuverability and Efficiency
In a significant advancement for aerospace engineering, researchers at the Massachusetts Institute of Technology (MIT) have developed a novel propulsion…
Read More
Boehringer Ingelheim eyes MASH as the next front for survodutide, a GLP-1/glucagon receptor dual agonist
Neeraja Balachander, who oversees Boehringer Ingelheim’s extensive cardio-renal-metabolic portfolio, articulated the company’s ambitious vision. “We have a program in MASH,…
Read More
Discovery of Fam102a as a Dual Regulator of Bone Remodeling Offers New Horizons for Osteoporosis Treatment
A breakthrough in skeletal biology has emerged from the Institute of Science Tokyo, where researchers have identified a previously misunderstood…
Read More
MIT Engineers Develop Dual Mode Propulsion System Integrating Chemical and Electric Thrusters for Small Satellites
In a significant advancement for aerospace engineering, researchers at the Massachusetts Institute of Technology (MIT) have successfully demonstrated a unified…
Read More
Boehringer Ingelheim eyes MASH as the next front for survodutide, a GLP-1/glucagon receptor dual agonist.
For decades, metabolic dysfunction-associated steatohepatitis (MASH), the more severe inflammatory form of fatty liver disease, was a silent epidemic, often…
Read More
MIT Engineers Uncover Dual Mechanism of Exercise-Induced Nerve Growth Through Biochemical and Physical Signaling
Recent breakthroughs in bioengineering at the Massachusetts Institute of Technology have fundamentally altered the scientific understanding of the relationship between…
Read More
Discovery of Fam102a Protein as a Dual Regulator of Bone Remodeling Offers New Horizons for Osteoporosis Treatment
A breakthrough study led by researchers at the Institute of Science Tokyo has identified a critical protein, Fam102a (Family with…
Read More
Discovery of Fam102a as a Dual Regulator in Bone Remodeling Offers New Pathways for Osteoporosis Treatment
In a significant advancement for regenerative medicine and skeletal health, a team of researchers at the Institute of Science Tokyo…
Read More
Researchers Uncover Dual-Ligase Mechanism for Targeted Protein Degradation, Paving Way for More Robust and Durable Cancer Therapies
A groundbreaking study has identified a novel mechanism by which a single small molecule can leverage two distinct cellular pathways…
Read More
